Havelange, V., & Demoulin, J. (2013). Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia. Dove Medical Press.
Citação norma ChicagoHavelange, Violaine, and Jean-Baptiste Demoulin. Review of Current Classification, Molecular Alterations, and Tyrosine Kinase Inhibitor Therapies in Myeloproliferative Disorders With Hypereosinophilia. Dove Medical Press, 2013.
MLA CitationHavelange, Violaine, and Jean-Baptiste Demoulin. Review of Current Classification, Molecular Alterations, and Tyrosine Kinase Inhibitor Therapies in Myeloproliferative Disorders With Hypereosinophilia. Dove Medical Press, 2013.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.